Blog - June 2018

Mitigating the risk: manufacturing high potency drugs

06 June 2018
By ChargePoint Technology

A growing demand for highly potent active pharmaceutical ingredients (HPAPIs), twinned with the prevalence of oncological, immunosuppressant and hormone-based products is fuelling need for high potency handling capabilities. 

ChargePoint Technology's very own Michael Avraam discusses the potential issues with containment performance testing, data collection and interpretation and how these may affect end user with Pharma Focus Asia. You can read the full article (pg.50) here

ChargePoint Technology at Achema 2018

01 June 2018
By ChargePoint Technology

We will be showcasing at Achema from 11th-15th June. Visit us in hall 3.0, Stand D14 to view our range of containment valves and get a sneak preview of our new technology, VERIFI. 

ChargePoint are the market leaders in powder containment and aseptic transfer valves. We can provide you with operator safety and sterility assurance for pharmaceutical, biotech, chemical and other process industries. 

Subscribe to RSS Feed